The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial
Open accessAbstract
OBJECTIVE: The aim of this trial was to compare the efficacy of real-time and intermittently scanned continuous glucose monitoring (rtCGM and isCGM, respectively) in maintaining optimal glycemic control. RESEARCH DESIGN AND METHODS: In this randomized study, adults with type 1 diabetes (T1D) and normal hypoglycemia awareness (Gold score <4) used rtCGM (Guardian Connect Mobile) or isCGM (FreeStyle Libre) during 4 days of physical activity (exercise phase) and in the subsequent 4 weeks at home (home phase). Primary end points were time in hypoglycemia (<3.9 mmol/L [<70 mg/dL]) and time in range (3.9–10.0 mmol/L [70–180 mg/dL]). The isCGM group wore an additional masked Enlite sensor (iPro2) for 6 days to check for bias between the different sensors used by the rtCGM and isCGM systems. RESULTS: Sixty adults with T1D (mean age 38 ± 13 years; A1C 62 ± 12 mmol/mol [7.8 ± 1.1%]) were randomized to rtCGM (n = 30) or isCGM (n = 30). All participants completed the study. Percentage of time in hypoglycemia (<3.9 mmol/L [<70 mg/dL]) was lower among rtCGM versus isCGM participants in the exercise phase (6.8 ± 5.5% vs. 11.4 ± 8.6%, respectively; P = 0.018) and during the home phase (5.3 ± 2.5% vs. 7.3 ± 4.4%, respectively; P = 0.035). Hypoglycemia differences were significant and most notable during the night. rtCGM participants spent more time in range (3.9–10 mmol/L [70–180 mg/dL]) than isCGM participants throughout both the exercise (78.5 ± 10.2% vs. 69.7 ± 16%, respectively; P = 0.0149) and home (75.6 ± 9.7% vs. 67.4 ± 17.8%, respectively; P = 0.0339) phases. The results were robust to the insignificant bias between rtCGM and isCGM sensors that masked CGM found in the isCGM arm. CONCLUSIONS: rtCGM was superior to isCGM in reducing hypoglycemia and improving time in range in adults with T1D with normal hypoglycemia awareness, demonstrating the value of rtCGM alarms during exercise and in daily diabetes self-management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Patient preference surveys consistently favored rtCGM systems over isCGM (Hašková et al., 2020)”
From Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis (2025) · cites this paper as Hašková et al., 2020
Experimental — accuracy not yet measuredIn the citing paper
“In two of the studies, the primary outcome was a reduction in time spent in hypoglycemia, and rtCGM showed greater benefits compared with isCGM (89,90).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
THE WHOQOL GROUP (1998) · Psychological Medicine · doi:10.1017/s0033291798006667 · Cited by 7,933
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationInternational consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Self-citationBeck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522
Polonsky, W. H., Hessler, D., Ruedy, K. J., & Beck, R. W. (2017) · Diabetes Care · doi:10.2337/dc17-0133 · Cited by 346
Flagged first, then by citations
1 of the 21 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–146 of 146
Sugai, K., Sasaki, J., Tomizawa, G., & Suzuki, R. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70233 · Cited by 2
The Transplantation of Pancreatic Islets to Portal Vein: The Influence on Liver Tissue
Vojtíšková, A., Fábryová, E., Berková, Z., Koblas, T., Girman, P., & Kříž, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031419 · Cited by 2
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · Diabetes Spectrum · doi:10.2337/ds22-0085 · Cited by 3
Mark‐Wagstaff, C., Deshmukh, H., Wilmot, E. G., Walker, N. M., Barnes, D., Parfitt, V. J., Saunders, S., Gregory, R., Choudhary, P., Patmore, J., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15283 · Cited by 2
Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes
Barbara, A. M., & Grobelna, A. (2022) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2022.419 · Cited by 2
Sehgal, S., Boucsein, A., Styles, S. E., Palmer, O., Paul, R. G., Crocket, H. R., de Bock, M. I., & Wheeler, B. J. (2023) · Diabetic Medicine · doi:10.1111/dme.15168 · Cited by 3
Isitt, J. J., & Roze, S. (2022) · Diabetic Medicine · doi:10.1111/dme.14989 · Cited by 2
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., Prahalad, P., Schweiger, D. Š., & Shalitin, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.2508 · Cited by 1
Santana-Mejía, J. A., & Romo-López, Á. G. (2025) · MQRInvestigar · doi:10.56048/mqr20225.8.4.2024.7780-7809 · Cited by 1
Sakane, N., Kato, K., Hata, S., Nishimura, E., Araki, R., Kouyama, K., Hatao, M., Matoba, Y., Matsushita, Y., Domichi, M., et al. (2025) · Diabetology International · doi:10.1007/s13340-025-00846-6 · Cited by 1
Wang, Y., Zhang, C., Zhao, H., Wang, C., Guo, L., Wei, P., Jin, M., Li, A., Li, Q., & Pan, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1693381 · Cited by 1
The Application of Digital Health in Diabetes Management
Ye, J. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v66i.11711 · Cited by 1
Glucose Differences Between Continuous Glucose Monitor Brands and Application Sites
Pham, K., Liu, X., Shek, A., & Shah, S. A. (2024) · Digital Medicine and Healthcare Technology · doi:10.5772/dmht.27 · Cited by 1
Putula, E., Hannula, P. M., Huhtala, H., & Metso, S. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100072 · Cited by 1
Afentakis, I., Unsworth, R., Herrero, P., Oliver, N. S., Reddy, M., & Georgiou, P. (2023) · doi:10.36227/techrxiv.22325803.v2 · Cited by 1
Diabetes mellitus management strategies in athletes
Dergacheva, L., Анатольевич, Д. А., Vykhodets, I. Т., Pavlova, A. A., & Парастаев, С. А. (2021) · Medicine of Extreme Situations · doi:10.47183/mes.2021.034
Protección penal de la intimidad de los usuarios de sistemas informáticos e internet0
Recio, F. G. (2007) · Estudios jurídicos
Metabolic and cardiovascular risk factors associated with type 1 Diabetes Mellitus in pediatric age
Araújo, M., & Correia, C. C. (2022) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ar210013
Yamamoto, J. M., & Murphy, H. R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.2506
Sakane, N., Kato, K., Hata, S., Nishimura, E., Araki, R., Kouyama, K., Hatao, M., Matoba, Y., Matsushita, Y., Domichi, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1984365/v1
Oliver, N. S. (2022) · Diabetic Medicine · doi:10.1111/dme.14967
Afentakis, I., Unsworth, R., Herrero, P., Oliver, N. S., Reddy, M., & Georgiou, P. (2023) · doi:10.36227/techrxiv.22325803
Afentakis, I., Unsworth, R., Herrero, P., Oliver, N. S., Reddy, M., & Georgiou, P. (2023) · doi:10.36227/techrxiv.22325803.v1
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · doi:10.2337/figshare.22714573
Saxena, R. K., Singh, A. B., & .Singh, D. N. P. (2023) · International Journal of Life Science and Pharma Research · doi:10.22376/ijlpr.2023.13.4.sp6.l87-l99
Zhou, Y., Elbalshy, M. M., Styles, S. E., Crocket, H. R., Jefferies, C., Wiltshire, E. J., de Bock, M. I., & Wheeler, B. J. (2023) · Pediatric Diabetes · doi:10.1155/2023/3435944
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., Prahalad, P., Schweiger, D. Š., & Shalitin, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2508
Perfilando la tecnología en diabetes
Gómez, N. B., Jiménez-Salazar, S., Delgado, M. R., Botero, J. F., & Rincón, A. R. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.1.852
Comité de Innovación. Uso de los sistemas de infusión continua de insulina en personas con DM1
Carnero, R., Saleme, A., Lequi, L., Daín, A., Campos, F. S., Sosa, L., Flores, A., & Kabakian, L. (2024) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v58i1sup.763
Flash glucose monitoring in diabetes
Lameijer, A. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.1021051970
Deniz, M. S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006990 · Cited by 1
Tecnología aplicada a la diabetes
Cebada, A. B., Silva, J. B. Q., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.004
Impacto del inicio de la monitorización flash de glucosa en pacientes adultos con diabetes tipo 1
Sahagún, R. J. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/72390
Santana-Mejía, J. A., & Romo-López, Á. G. (2025) · MQRInvestigar · doi:10.56048/mqr20225.9.1.2025.e6
Glucose meters and sensors for type 1 diabetes (part 2)
Slee, P. H. T. J., Helmerhorst, F. M., & Nieuwhof, M. (2023) · Geneesmiddelenbulletin · doi:10.35351/gebu.2023.6.10
Nugroho, Y. W., & Nani, D. (2025) · HOLISTIK JURNAL KESEHATAN · doi:10.33024/hjk.v19i5.583
Chacón, R. P., Ceballos, L. T., Jiménez, A. B. A., Gómez‐Perea, A., Hinojosa, J. M. J., López‐Siguero, J. P., & Gea, I. L. (2025) · Diseases · doi:10.3390/diseases13080254
Eviz, E., Karakus, K. E., Gökçe, T., Can, E., Mutlu, G. Y., & Hatun, Ş. (2025) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2025.2025-1-7
Batir, D. M., Boev, M., Gurău, G., Matei, M. N., Nechita, A., & Maftei, N.-M. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014475
Hayek, A. A., Zahrani, W. M. A., Alotaibi, H. F., Saleh, J. Y., & Dawish, M. A. A. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.04.002
Kongdee, R., Bijan Parsia, A., Thabit, H., & Harper, S. (2026) · Scientific Data · doi:10.1038/s41597-026-07189-0
Masuda, T., Katakami, N., Taya, N., Miyashita, K., Takahara, M., Kato, K., & Shimomura, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag224
Exploring the Benefits of Digital Health Technologies in Diabetes Management
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8238-1
Schwensfeier, L., & Brinkmann, C. K. (2026) · Sports · doi:10.3390/sports14070274
Diabetes Technology in Children
Zhou, Y., & Wheeler, B. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-24854-1_14
Metadata
- Authors
- Hásková, A., Radovnická, L., Petruželková, L., Parkin, C. G., Grunberger, G., Horová, E., Navrátilová, V., Kádě, O., Matoulek, M., Prázný, M., & Šoupal, J.
- Affiliations
- 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- Masaryk Hospital, Ústí nad Labem, Czech Republic
- Charles University (CZ)
- CGParkin Communications, Inc., Henderson, NV
- Grunberger Diabetes Institute (US)
- Corresponding author
- Šoupal, Jan
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-08-28
- Volume
- 43
- Issue
- 11
- Pages
- 2744-2750
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7576432
- OpenAlex
- W3082218057
- Cited by
- 146
- References
- 21
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 28 · 2023: 39 · 2022: 37 · 2021: 15
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research (AZV) of the Czech Republic and Ministry of Health of the Czech Republic (15-26705A)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, real-time continuous glucose monitoring, intermittently scanned continuous glucose monitoring, glycemic control, hypoglycemia, time in range, physical activity, sensor bias, hypoglycemia awareness, FreeStyle Libre, HbA1c, hypoglycemia risk reduction
- MeSH terms
- Glycemic Control, Adult, Blood Glucose, Computer Systems, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Blood Glucose Self-Monitoring, Exercise, Treatment Outcome, Computers, Handheld
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review